About Us
Mission
Members
Board of Directors
Staff
Annual Meeting
COVID-19 Response
Economic Impact
Issues
PAMA
Economic Impact of Clinical Labs
Protecting Access to Medicare Act
Laboratory Developed Tests
Reimbursement and Coverage
Patient Access to Lab Services
Value of Labs
IOAS Exception and Self-Referral
Regulatory Issues
Value of Health IT Data Standards
TRICARE Non-Coverage of LDTs
Take Action
News
ACLA Blog
ACLA Press Releases
Comments and Letters
ACLA In The News
Resources
CPT Committee
NGS NCD Work Group
Prior Authorization Work Group
Join Us
Home
Contact Us
Home
Contact Us
About Us
Mission
Members
Board of Directors
Staff
Annual Meeting
COVID-19 Response
Economic Impact
Issues
PAMA
Economic Impact of Clinical Labs
Protecting Access to Medicare Act
Laboratory Developed Tests
Reimbursement and Coverage
Patient Access to Lab Services
Value of Labs
IOAS Exception and Self-Referral
Regulatory Issues
Value of Health IT Data Standards
TRICARE Non-Coverage of LDTs
Take Action
News
ACLA Blog
ACLA Press Releases
Comments and Letters
ACLA In The News
Resources
CPT Committee
NGS NCD Work Group
Prior Authorization Work Group
Join Us
Protecting Access to Medicare Act
Medicare Part B Clinical Laboratory Fee Schedule: Guidance to Laboratories for Collecting and Reporting Data for the Private Payor Rate-Based Payment System
August 10, 2016
Categories:
Protecting Access to Medicare Act
,
Regulatory Issues
Download (PDF, 116KB)
Print page / Save as PDF
